Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases.

Seifried S, Haydu LE, Quinn MJ, Scolyer RA, Stretch JR, Thompson JF.

Ann Surg Oncol. 2015;22(6):1959-66. doi: 10.1245/s10434-014-4215-3. Epub 2014 Nov 11.

PMID:
25384702
2.

Clinicopathologic study of 85 cases of melanoma of the female genitalia.

Tcheung WJ, Selim MA, Herndon JE 2nd, Abernethy AP, Nelson KC.

J Am Acad Dermatol. 2012 Oct;67(4):598-605. doi: 10.1016/j.jaad.2011.11.921. Epub 2012 Jan 13.

PMID:
22243767
3.

Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.

Murali R, Haydu LE, Long GV, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Kefford RF, Thompson JF, Scolyer RA.

Ann Surg Oncol. 2012 Jun;19(6):1782-9. doi: 10.1245/s10434-012-2265-y. Epub 2012 Feb 14.

PMID:
22350600
4.

Conservative surgery for vulvovaginal melanoma.

Rogo KO, Andersson R, Edbom G, Stendahl U.

Eur J Gynaecol Oncol. 1991;12(2):113-9.

PMID:
2055225
5.

The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.

MacKenzie Ross AD, Haydu LE, Quinn MJ, Saw RP, Shannon KF, Spillane AJ, Stretch JR, Scolyer RA, Thompson JF.

Ann Surg Oncol. 2016 Apr;23(4):1082-9. doi: 10.1245/s10434-015-4942-0. Epub 2015 Nov 11.

PMID:
26561405
6.

Melanomas of the vulva and vagina.

Trimble EL.

Oncology (Williston Park). 1996 Jul;10(7):1017-23; discussion 1024. Review.

7.

Malignant vulvo-vaginal melanoma: a report of 7 cases.

González-Bosquet J, García Jiménez A, Gil Moreno A, Xercavins J.

Eur J Gynaecol Oncol. 1997;18(1):63-7.

PMID:
9061328
8.

Melanomas of vulva and vagina.

Fenn ME, Abell MR.

Obstet Gynecol. 1973 Jun;41(6):902-11. No abstract available.

PMID:
4708486
9.

Malignant melanoma of the vulva: an extension of cutaneous melanoma?

Moxley KM, Fader AN, Rose PG, Case AS, Mutch DG, Berry E, Schink JC, Kim CH, Chi DS, Moore KN.

Gynecol Oncol. 2011 Sep;122(3):612-7. doi: 10.1016/j.ygyno.2011.04.007. Epub 2011 May 14.

PMID:
21570710
10.

Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center.

Haydu LE, Stollman JT, Scolyer RA, Spillane AJ, Quinn MJ, Saw RP, Shannon KF, Stretch JR, Bonenkamp JJ, Thompson JF.

Ann Surg Oncol. 2016 Apr;23(4):1071-81. doi: 10.1245/s10434-015-4575-3. Epub 2015 May 9.

PMID:
25956574
11.

Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.

Harcharik S, Bernardo S, Moskalenko M, Pan M, Sivendran M, Bell H, Hall LD, Castillo-Martín M, Fox K, Cordon-Cardo C, Chang R, Sivendran S, Phelps RG, Saenger Y.

J Am Acad Dermatol. 2014 Jun;70(6):1036-44. doi: 10.1016/j.jaad.2014.01.914. Epub 2014 Mar 31.

PMID:
24698703
12.

Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.

Thomas NE, Kricker A, Waxweiler WT, Dillon PM, Busman KJ, From L, Groben PA, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Venn A, Kanetsky PA, Orlow I, Paine S, Ollila DW, Reiner AS, Luo L, Hao H, Frank JS, Begg CB, Berwick M; Genes, Environment, and Melanoma (GEM) Study Group.

JAMA Dermatol. 2014 Dec;150(12):1306-314.

13.

Vulvar/vaginal melanoma: an updated surveillance epidemiology and end results database review, comparison with cutaneous melanoma and significance of racial disparities.

Mert I, Semaan A, Winer I, Morris RT, Ali-Fehmi R.

Int J Gynecol Cancer. 2013 Jul;23(6):1118-25. doi: 10.1097/IGC.0b013e3182980ffb.

PMID:
23765206
14.

Primary malignant melanoma of the vagina and vulva.

Ragni MV, Tobon H.

Obstet Gynecol. 1974 May;43(5):658-64. No abstract available.

PMID:
4822650
15.

Vulvovaginal melanoma: report of seven cases and literature review.

Brand E, Fu YS, Lagasse LD, Berek JS.

Gynecol Oncol. 1989 Apr;33(1):54-60. Review.

PMID:
2649420
16.

Female genital tract melanoma: the evidence is only skin deep.

Rodriguez AO.

Curr Opin Obstet Gynecol. 2005 Feb;17(1):1-4. No abstract available.

PMID:
15711404
17.

Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.

Finley JW, Gibbs JF, Rodriguez LM, Letourneau R, Driscoll D, Kraybill W.

Am Surg. 2000 Jun;66(6):527-31; discussion 531-2.

PMID:
10888127
18.

Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.

Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA.

Ann Surg. 2012 Jan;255(1):128-33. doi: 10.1097/SLA.0b013e3182306c72.

PMID:
21975320
19.

Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role?

Ribero S, Osella-Abate S, Sanlorenzo M, Balagna E, Senetta R, Fierro MT, Macripò G, Macrì L, Sapino A, Quaglino P.

Ann Surg Oncol. 2015;22(6):1967-73. doi: 10.1245/s10434-014-4211-7. Epub 2014 Nov 12.

20.

The management of cervical lymph nodes in patients with cutaneous melanoma.

Martin RC, Shannon KF, Quinn MJ, Saw RP, Spillane AJ, Stretch JR, Colman MH, Gao K, Thompson JF.

Ann Surg Oncol. 2012 Nov;19(12):3926-32. doi: 10.1245/s10434-012-2374-7. Epub 2012 Jun 6.

PMID:
22669449

Supplemental Content

Support Center